Panos Konstantinopoulos, MD, PhD shares results of a phase 2 endometrial cancer study at 2022 SGO.
2 Visualizações
• 07/17/23
0
0
Embutir
administrator
Assinantes
Panos Konstantinopoulos, MD, PhD shares results of a phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer at the 2022 Society for Gynecologic Oncology Annual Meeting.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários